Clinical Trials Logo

Clinical Trial Summary

We retrospectively review patients with refractory or relapsed ENKL who received a gemcitabine-containing regimen


Clinical Trial Description

n/a


Study Design

Observational Model: Cohort, Time Perspective: Retrospective


Related Conditions & MeSH terms


NCT number NCT01660568
Study type Observational
Source Samsung Medical Center
Contact
Status Completed
Phase N/A
Start date August 2012
Completion date January 2013

See also
  Status Clinical Trial Phase
Not yet recruiting NCT04899414 - Dexamethasone, Azacytidine,Pegaspargase and Tislelizumab for NK/T Cell Lymphoma Phase 2
Recruiting NCT05627856 - A Study of GNC-038 Injection in Patients With Relapsed or Refractory NK/ T-cell Lymphoma, AITL, and Other NHL Phase 1/Phase 2
Not yet recruiting NCT05208853 - An Exploratory Clinical Study Evaluating the Safety and Efficacy of Anti CD30 CAR T Cells in Patients With CD30+ Relapsed/Refractory Lymphoma Early Phase 1
Withdrawn NCT04230330 - Nivolumab in Combination With GDP/ L-asparaginase in NK/ T-cell Lymphoma Phase 1
Recruiting NCT04004637 - CD7 CAR-T Cells for Patients With R/R CD7+ NK/T Cell Lymphoma,T-lymphoblastic Lymphoma and Acute Lymphocytic Leukemia Phase 1
Recruiting NCT04038411 - PD-1 Antibody, Chidamide, Lenalidomide and Etoposide for Relapsed or Refractory NK/T Cell Lymphoma Phase 4